Gilead Sciences Cash from Other Financing Activities (Quarterly) Analysis

Gilead Sciences, Inc. (GILD)

147.42 -0.22 (-0.15%) USD | NASDAQ | Feb 25, 13:08

View Cash from Other Financing Activities (Quarterly) for GILD.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Cash from Other Financing Activities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Cash from Other Financing Activities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Cash from Other Financing Activities (Quarterly) Benchmarks

Start Trial

Amgen, Inc.	Upgrade
Johnson & Johnson	Upgrade
Eli Lilly & Co.	Upgrade
Regeneron Pharmaceuticals, Inc.	Upgrade
Moderna, Inc.	Upgrade